FDA Updates Standards for Biologics
The Food and Drug Administration is amending standards for general biological products to remove outdated and duplicative requirements, it said in a direct final rule (here). Among other changes, the agency is changing standards relating to dating periods and removing some provisions on standard preparations and limits of potency, it said. The direct final rule takes effect Sept. 16, 2016, unless FDA receives comments opposing the changes and withdraws the amendments. FDA also issued an identical proposed rule (here) it will consider if it withdraws the direct final rule.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
(Federal Register 05/04/16)